Dalton Pharma Services Expands its Contract Analytical Services
"Our commitment to accelerate the drug discovery and development process continues as we add to our state-of-the-art instrumentation to support GMP API synthesis, sterile dose formulation and sterile fill, method validation and other outsourced analytical projects including stability studies, bioanalytical development and analysis," said Peter Pekos, President and CEO. Dalton continues to develop and grow its analytical capabilities to enhance it's commitment to quality, responsiveness, flexibility and innovation through the supply of unparalleled contract pharmaceutical development services.
Most read news
Organizations
Other news from the department business & finance
These products might interest you
Genomics & Analytical Services by Azenta
Integrated Genomics & Analytical Services from Azenta Life Sciences
Discovery can be challenging work. Until you find the right genomics partner.
Pharmaceutical Development Services by AR2i
Take Advantage of AR2i's Analytical Knowledge and Unique Expertise
Our Pharmaceutical Laboratory Services According to the European Pharmacopoeia or Client Needs
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.